medigraphic.com
ISSN 1561-3062 (Electronic)

2015, Number 3

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2015; 41 (3)

Epidemiology of endometrial cancer

Tamayo LTG, Couret CMP

Language: Spanish
References: 36
Page:
PDF size: 229.37 Kb.


ABSTRACT

Introduction: endometrial adenocarcinoma is the fourth leading cause of cancer among women in developed countries. While genetic and hereditary factors account for 5-10% of the known causes of cancer, environmental factors and lifestyle account for over 90% remaining.
Objectives: to characterize endometrial adenocarcinoma in Ramón González Coro Hospital in 2008, with regard to determining the frequency of the disease by age groups and skin color, to present the main epidemiological antecedents of risk, and to determine the most frequent stages and their links with the selected variables.
Methods: the design was descriptive, observational, cross-sectional and retrospective. 47 biopsy reports were analyzed as belonging to the patients affected by endometrial cancer.
Results: 72.34% of the patients had white skin. 46.80% were in the age group of 60-75 years. Hypertension was present in 74.4%, followed by diabetes and obesity with 63.83% and 42.55%, respectively. 74.47% had endometrial carcinoma. 86% of the well-differentiated lesions were in stage I.
Conclusions: the age group of 60-75 years showed the highest percentages of presentation, regardless of skin color. More than half of the patients had two or three risk factors. Endometrial carcinoma predominated. There was an association between the stage and the degree of differentiation of the lesion, but not with the histological subtype.


REFERENCES

  1. Orellana R, Saavedra F, Montero JC, Cisterna P, Olguín F, Torretti M, et al. Cáncer de endometrio: experiencia de 10 años en el hospital San Juan de Dios. Rev. chil. obstet. ginecol. [revista en la Internet]. 2013 [citado 2015 Ene 25];78(6):441-46. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262013000600007&lng=es . http://dx.doi.org/10.4067/S0717-75262013000600007.

  2. Chiang, Jing Wang. Uterine Cancer. Hypertension, 2009;2:3.

  3. Montero León JF. Adenocarcinoma de endometrio. Nueva estrategia terapéutica. La Habana, Cuba. Abril 2013. Material docente virtual en CD.

  4. Sánchez C, Ibáñez C, Klaassen J. Obesidad y cáncer: la tormenta perfecta. Rev. méd. Chile. [Revista en la Internet]. 2014 sept [citado 2014 sept 12];142 (2). Disponible en: http://dx.doi.org/10.4067/S0034-98872014000200010

  5. Dedes K, Wetterskog D, Ashworth A, Stan B, Kaye S, Reis-Filho J. Emerging therapeutic targets in endometrial cancer. Nature Reviews Clinical Oncology. 2008;8:261-71.

  6. Cunningham F.et al. Endometrial Cancer. Williams Gynecology. The McGraw-Hill Companies. 22 edit. 2008. [citado 2014 sept 12]. Disponible en: http://www.accessmedicine.com/popup.aspx?aID=316 ).

  7. García E, Martínez P, Guinot JL, Poveda A, Almenar S, Labrador T, Morales J. Guía clínica del adenocarcinoma de endometrio. Fundación Instituto Valenciano de Oncología. Enero, 2007.

  8. Aguilar Vela de Oro O, Díaz Mitjans O, Soriano García JL. Adenocarcinoma de endometrio. Guías de Diagnóstico y Tratamiento en Oncología. 2006.

  9. Sorosky JI. Endometrial cáncer. Obstet gynecol. 2008;111:436-47.

  10. Barakat RR, Merkman M, Randall M. Principles and practice of gynecologic oncology. 5th edition. Philadelphia. Wolters Kluwer Health/Lippincolt. Williams &Wilkins; 2009.

  11. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.

  12. Sorosky JI. Endometrial cancer. Obstet Gynecol 2012; 120:383–97.

  13. Mikuta JJ. Internacional Federation of Gynecology and Obstetric Staging of Endometrial Cancer. Cancer. 1988;71:1460-70.

  14. García Miralles T, Menéndez P, Astudillo González A. Factores pronósticos anatomopatológicos de 1ª y 2ª generación en el carcinoma de endometrio. Hospital Central de Asturias. 1998. Última actualización: 01 noviembre 1998 22:08. [Citado: 2 de enero de 2015]. Disponible en: http://www.uninet.edu/conganat/IICVHAP/conf/002/

  15. Tamayo y Tamayo M. Serie: Aprender a investigar. Módulo 2 .3ª Edición: (corregida y aumentada) 1999. [Citado: 2 de enero de 2015]. Disponible: http://es.slideshare.net/chris6757/modulo-5-tamayo-y-tamayo-investigacion

  16. Garg K, Soslow R. Endometrial carcinoma in women aged 40 years and younger. Archives of Pathology & Laboratory Medicine [serial on the Internet]. (2014 Mar), [cited: January 25, 2015]; 138(3): 335-342. Disponible en: http://web.a.ebscohost.com/ehost/detail/detail?vid=12&sid=0505f6cf-5a88-4049-b49d-417ac250f7df%40sessionmgr4005&hid=4212&bdata=Jmxhbmc9ZXMmc2l0ZT1laG9zdC1saXZl#db=mdc&AN=24576029

  17. Bereck, Jonathan S, Hacker, Neville E. Ginecología Oncológica práctica. 4th ed. Philadelphia. Wolters Kluwer Health/Lippincolt. Williams &Wilkins; 2005.

  18. Bakkum-Gamez, Jamie N, Gonzalez-Bosquet J, Laack N, Mariani A, Dowdy S. Current Issues in the Management of Endometrial Cancer. Mayo Clin Proc. January 2008;83(1):97-112.

  19. Crispens, Marta Ann. Endometrial Cancer. En: Te Linde´s Operative Gynecology. USA. Ed. Lippincott Williams & Wilkins. 2008. P 1292-307.

  20. Narducci F, Occel. B. Le cáncer de L'endometre. Epidemiologie; anatomopathlogie; despistage; diagnostic; evolution pronostic; principes du traitemente. Bull Cáncer 1998;85(4):363-73.

  21. González Merlo J, Lejarcegui FL. Adenocarcinoma del endometrio en: González Merlo J. Oncología Ginecológica. España: Salvat Editores. S.A; 1995:211-54.

  22. Enríquez B, Fuentes L, Jo va Rodríguez M, Robaina F. Estudio clínico-epidemiológico del adenocarcinoma del endometrio y sus precursores. Rev Cubana Obstet Ginecol [revista en la Internet]. 2003 Dic [citado 2014 Oct 10];29(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2003000300009&lng=es .)

  23. Pérez R, Pontillo H, Urbistazu J, Giménez M, Bracho G, Borges A. Epidemiología y factores de riesgo en pacientes con adenocarcinoma de endometrio. Rev. venez. oncol . 2007;19(4):313-20.

  24. Arem H, Park Y, Pelser C, Ballard-Barbash R, Irwin M, Matthews C, et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. Journal Of The National Cancer Institute [serie en internet]. 2013 Mar [citado Oct 11,2014];105(5):342-49. Disponible en: MEDLINE Complete.http://web.a.ebscohost.com /ehost/pdfviewer/pdfviewer?vid=11&sid=e384cacd-2c19-446f-8f5c-3330001b84c9%40sessionmgr4003&hid=4201

  25. Arem H, Irwin ML. Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond). 2013[citado Oct 11,2014];37(5):634-9. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22710929

  26. MA Bittoni, JL Fisher, JM Fowler, GL Maxwell, and ED Paskett Assessment of the Effects of Severe Obesity and Lifestyle Risk Factors On Stage of Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. Jan 2013; 22(1): 76–81.

  27. Arem H, Chlebowski R, Stefanick ML, Anderson G, Wactawski-Wende J, Sims S, Gunter MJ, Irwin ML. Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative. See comment in PubMed Commons below Gynecol Oncol. 2013 Feb; 128(2):181-6.

  28. Arem H, Park Y, Pelser C, Ballard-Barbash R, Irwin ML,Hollenbeck A, Gierach GL,Brinton LA, Pfeiffer RM, Matthews CE. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013 Mar 6;105(5):342-9.

  29. Aranceta Bartrina Javier, Pérez Rodrigo Carmen. Relación entre el consumo de sacarosa y cáncer: una revisión de la evidencia. Nutr. Hosp. [revista en la Internet]. [citado 2015 Ene 25]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112013001000012&lng=es .

  30. Garmendia María Luisa, Ruiz Pablo, Uauy Ricardo. Obesidad y cáncer en Chile: estimación de las fracciones atribuibles poblacionales. Rev. méd. Chile [revista en la Internet]. 2013 Ago [citado 2015 Ene 25]; 141(8): 987-994. Disponible en: http://dx.doi.org/10.4067/S0034-98872013000800004.

  31. Luo J, Beresford S, Chen C, Chlebowski R, Garcia L, Margolis K, et al. Association between diabetes, diabetes treatment and risk of developing endometrial cancer. British Journal Of Cancer [serie en Internet]. (2014, Sep), [citado Oct 11,2014];111(7):1432-39. Disponible en: MEDLINE Complete. http://web.a.ebscohost.com/ehost/detail/detail? vid=23&sid=e384cacd-2c19-446f-8f5c-3330001b84c9%40sessionmgr 4003&hid=4201&bdata =Jmxhbmc9ZXMmc2l0ZT1laG9zdC1saXZl#db=mdc&AN=25051408

  32. Han G, Sidhu D, Duggan M, Arseneau J, Cesari M, Köbel M, et al. Reproducibility of histological cell type in high-grade endometrial carcinoma. Modern Pathology: An Official Journal Of The United States And Canadian Academy Of Pathology, Inc [serie en Internet]. 2013 Dic [citado 2015 Ene 25]; 26(12):1594-04. Disponible en:MEDLINEComplete. http://web.a.ebscohost.com/ehost/detail/detail?vid=17&sid=0505f6cf-5a88-4049-b49d-417ac250f7df%40sessionmgr4005&hid=4212&bdata=Jmxhbmc9ZXMmc2l0ZT1laG9zdC1saXZl#db=mdc&AN=23807777

  33. Baquedano M Laura, Puig F Fernando, Rubio C Patricia, Angel Ruiz C Miguel. Adenocarcinoma de endometrio de patrón sertoliforme. Rev. chil. obstet. ginecol. [revista en la Internet]. 2012 [citado 2015 Ene 25]; 77(6): 453-456. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262012000600009&lng=es . http://dx.doi.org/10.4067/S0717-75262012000600009.

  34. Díaz Ortega Israel, Martínez Martínez-Pinillo Ángela Felicia, Morera Pérez Maricela, Barreras González Javier Ernesto, Montero León Jorge Felipe, Amigó de Quesada Margarita. Estadiamiento videolaparoscópico en el adenocarcinoma de endometrio. Rev Cubana Obstet Ginecol [revista en la Internet]. 2014 Mar [citado 2015 Ene 25]; 40(1): 58-67. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2014000100007&lng=es .

  35. Mendivil A1, Schuler KM, Gehrig PA. Non-Endometrioid Adenocarcinoma of the Uterine Corpus: Review of Selected Histological Subtypes. Cancer Control. 2009 Jan;16(1):46-52.

  36. Pérez Echemendía, M. Ginecología oncológica pelviana. 2a ed. La Habana: Editorial Ciencias Médicas; 2012. p. 57-67.




2020     |     www.medigraphic.com